Academics are questioning whether Australian oncology guidelines can be trusted after finding that at least 25% of the authors have undisclosed links with industry. A review of 33 NHMRC-endorsed clinical guidelines – including four covering cancer – found that only 14% of guideline authors disclosed any financial conflicts of interest. But one in four of ...
Already a member?
Enter your email to keep reading.